236 related articles for article (PubMed ID: 26597434)
1. Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome.
Conrad MA; Cui J; Lin HC
J Pediatr; 2016 Feb; 169():313-5.e1. PubMed ID: 26597434
[TBL] [Abstract][Full Text] [Related]
2. Acute hepatitis with prolonged cholestasis and disappearance of interlobular bile ducts following tibolone and Hypericum perforatum (St. John's wort). Case of drug interaction?
Etogo-Asse F; Boemer F; Sempoux C; Geubel A
Acta Gastroenterol Belg; 2008; 71(1):36-8. PubMed ID: 18396749
[TBL] [Abstract][Full Text] [Related]
3. [A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis].
Yoon JY; Min SY; Park JY; Hong SG; Park SJ; Paik SY; Park YM
Korean J Hepatol; 2008 Mar; 14(1):97-101. PubMed ID: 18367862
[TBL] [Abstract][Full Text] [Related]
4. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
5. [Acute cholestatic hepatitis probably caused by sertraline].
Galán Navarro JL
Rev Esp Enferm Dig; 2001 Dec; 93(12):822. PubMed ID: 11995366
[No Abstract] [Full Text] [Related]
6. Hepatobiliary and Pancreatic: Sertraline-induced vanishing bile duct syndrome treated with plasmapheresis.
Tejedor-Tejada J; García-Pajares F; Madrigal Rubiales B
J Gastroenterol Hepatol; 2019 Mar; 34(3):488. PubMed ID: 30536927
[No Abstract] [Full Text] [Related]
7. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
8. Meropenem-induced vanishing bile duct syndrome.
Schumaker AL; Okulicz JF
Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
[TBL] [Abstract][Full Text] [Related]
9. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole.
Altraif I; Lilly L; Wanless IR; Heathcote J
Am J Gastroenterol; 1994 Aug; 89(8):1230-4. PubMed ID: 8053440
[TBL] [Abstract][Full Text] [Related]
10. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
Xie W; Wang Q; Gao Y; Pan CQ
BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.
Davies MH; Harrison RF; Elias E; Hübscher SG
J Hepatol; 1994 Jan; 20(1):112-6. PubMed ID: 8201211
[TBL] [Abstract][Full Text] [Related]
12. Vanishing bile duct syndrome temporally associated with ibuprofen use.
Alam I; Ferrell LD; Bass NM
Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
[TBL] [Abstract][Full Text] [Related]
14. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
Rahier JF; Rahier J; Leclercq I; Geubel AP
Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
[TBL] [Abstract][Full Text] [Related]
15. Nonsyndromic paucity of intrahepatic bile ducts in infancy and idiopathic ductopenia in adulthood: the same syndrome?
Bruguera M; Llach J; Rodés J
Hepatology; 1992 May; 15(5):830-4. PubMed ID: 1568724
[TBL] [Abstract][Full Text] [Related]
16. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
[TBL] [Abstract][Full Text] [Related]
17. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review.
Levine C; Trivedi A; Thung SN; Perumalswami PV
Semin Liver Dis; 2014 May; 34(2):246-51. PubMed ID: 24879988
[TBL] [Abstract][Full Text] [Related]
18. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
[TBL] [Abstract][Full Text] [Related]
19. Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics.
Bessone F; Hernández N; Tanno M; Roma MG
Semin Liver Dis; 2021 Aug; 41(3):331-348. PubMed ID: 34130334
[TBL] [Abstract][Full Text] [Related]
20. [Drug-induced bile duct injury: progress and challenges].
Li DL
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
